Synthesis of drug-crosslinked polymer nanoparticles

2015 ◽  
Vol 6 (10) ◽  
pp. 1703-1713 ◽  
Author(s):  
Chen Xie ◽  
Chenchen Yang ◽  
Peng Zhang ◽  
Jialiang Zhang ◽  
Wei Wu ◽  
...  

A new kind of drug-crosslinked polymer nanoparticle was synthesized. The nanoparticles were composed by a phenylboronic acid modified 10-hydroxycamptothecin (the crosslinker) and 1,2-diol-rich PEG-PGMA diblock copolymer (the backbone), and crosslinked by phenylboronic ester bond.

2017 ◽  
Vol 8 (15) ◽  
pp. 2410-2422 ◽  
Author(s):  
Zihao Zhang ◽  
Yongjing Li ◽  
Jiaxun Wan ◽  
Peihua Long ◽  
Jia Guo ◽  
...  

A new kind of Pt(iv)-crosslinked polymer nanoparticle with small, uniform size and high loading of cisplatin has been prepared for greatly attenuating the detoxifying effect of Pt(ii) species.


2016 ◽  
Vol 52 (49) ◽  
pp. 7633-7652 ◽  
Author(s):  
Li Zhao ◽  
Chunsheng Xiao ◽  
Liyan wang ◽  
Guangqing Gai ◽  
Jianxun Ding

Glucose-sensitive polymer nanoparticles based on glucose oxidase, concanavalin A, or phenylboronic acid for self-regulated drug delivery have been reviewed.


Soft Matter ◽  
2019 ◽  
Vol 15 (1) ◽  
pp. 17-21
Author(s):  
Gregory N. Smith ◽  
Victoria J. Cunningham ◽  
Sarah L. Canning ◽  
Matthew J. Derry ◽  
J. F. K. Cooper ◽  
...  

Concentrated dispersions of polymer nanoparticles with high contrast can be studied using SESANS in real space.


2020 ◽  
Vol 11 (4) ◽  
pp. 889-899 ◽  
Author(s):  
Chunhui Gao ◽  
Yinghua Zhang ◽  
Yan Zhang ◽  
Shaoyong Li ◽  
Xinlin Yang ◽  
...  

The disulfide bond-crosslinked polymer nanoparticles based on iopamidol were prepared and then surface-modified with cRGD peptide through the linkages of PEG to acquire a CT contrast agent for breast cancer-targeted imaging.


2016 ◽  
Vol 52 (18) ◽  
pp. 3701-3704 ◽  
Author(s):  
Qianjin Li ◽  
Tripta Kamra ◽  
Lei Ye

Addition of crosslinked polymer nanoparticles into a solution of a 3-nitrophenylboronic acid–alizarin complex leads to significant enhancement of fluorescence emission.


Soft Matter ◽  
2016 ◽  
Vol 12 (48) ◽  
pp. 9683-9691 ◽  
Author(s):  
Huazhang Guo ◽  
Duanguang Yang ◽  
Mei Yang ◽  
Yong Gao ◽  
Yijiang Liu ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-14 ◽  
Author(s):  
Hongyun Ma ◽  
Weiqian Jiang ◽  
Jianxun Ding ◽  
Mingqiang Li ◽  
Yilong Cheng ◽  
...  

Malignant spinal tumors, categorized into primary and metastatic ones, are one of the most serious diseases due to their high morbidity and mortality rates. Common primary spinal tumors include chordoma, chondrosarcoma, osteosarcoma, Ewing’s sarcoma, and multiple myeloma. Spinal malignancies are not only locally invasive and destructive to adjacent structures, such as bone, neural, and vascular structures, but also disruptive to distant organs (e.g., lung). Current treatments for spinal malignancies, including wide resection, radiotherapy, and chemotherapy, have made significant progress like improving patients’ quality of life. Among them, chemotherapy plays an important role, but its potential for clinical application is limited by severe side effects and drug resistance. To ameliorate the current situation, various polymer nanoparticles have been developed as promising excipients to facilitate the effective treatment of spinal malignancies by utilizing their potent advantages, for example, targeting, stimuli response, and synergetic effect. This review overviews the development of polymer nanoparticles for antineoplastic delivery in the treatment of spinal malignancies and discusses future prospects of polymer nanoparticle-based treatment methods.


2017 ◽  
Vol 5 (2) ◽  
pp. 024001 ◽  
Author(s):  
Rodrigo A Ponzio ◽  
Yésica L Marcato ◽  
María L Gómez ◽  
Carolina V Waiman ◽  
Carlos A Chesta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document